Skip to main content
. 2015 May 8;8:192. doi: 10.1186/s13104-015-1153-5

Figure 2.

Figure 2

Number of patients presenting with distant intracranial progression within 365 days of randomisation for the first 100 patients accrued to the ANZMTG 01.07 WBRTMel Trial.